Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo

European Journal of Pharmacology
H RommelspacherU Wollert

Abstract

Harmane and other related beta-carbolines are putative endogenous ligands of the benzodiazepine receptor. Since the compounds are potent convulsants they may have agonist activities at the benzodiazepine receptor while the benzodiazepines may be antagonists. This hypothesis was proved by comparing the in vivo and in vitro antagonism of benzodiazepines by harmane and other beta-carbolines. Harmane is clearly a competitive inhibitor of benzodiazepine receptor binding in vitro. Moreover, harmane-induced convulsions can be inhibited reversibly by diazepam in a manner which is consistent with the assumption of competitive antagonism in vivo. For some beta-carboline derivatives a correlation was found between the affinity for the benzodiazepine receptor in vitro and the convulsive potency in vivo. Thus, the data reported suggest that harmane or other related beta-carbolines are putative endogenous agonists of the benzodiazepine receptor. This suggestion is further supported by the observation that diazepam is equally potent in inhibiting harmane- or picrotoxin-induced convulsions, indicating a convulsive mechanism within the GABA receptor-benzodiazepine receptor system.

References

Jan 1, 1976·Annual Review of Physiology·S H Snyder, J P Bennett
Jan 1, 1979·Annual Review of Pharmacology and Toxicology·E Costa, A Guidotti
Sep 24, 1979·Life Sciences·P J MarangosP Skolnick
Feb 26, 1979·Life Sciences·P J MarangosP Skolnick
Apr 1, 1978·European Journal of Pharmacology·C Braestrup, R F Squires
Apr 21, 1977·Nature·R F Squires, C Brastrup
Jan 18, 1980·Science·J F TallmanD W Gallager
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·C BraestrupC E Olsen
Oct 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·H RommelspacherU Wollert
Jan 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·D W ShoemakerM Evans

❮ Previous
Next ❯

Citations

Jan 1, 1985·Psychopharmacology·W M BournF O Risinger
Sep 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·H RommelspacherG Schmidt
May 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·K J FehskeW E Müller
Oct 1, 1984·Biulleten' eksperimental'noĭ biologii i meditsiny·A T Dolzhenko, I V Komissarov
Nov 1, 1991·Neurochemical Research·H KawasakiM Fukahori
Mar 23, 2013·Psychopharmacology·Katharine A BrennanPenelope Truman
Apr 22, 1982·Brain Research·K J Fehske, W E Muller
Mar 18, 1983·European Journal of Pharmacology·M H ThiébotP Simon
Mar 12, 1985·European Journal of Pharmacology·H RommelspacherR Hill
Aug 21, 1987·European Journal of Pharmacology·J H TrouvinC Jacquot
Dec 1, 1983·Neuropharmacology·C A BoastK M Bergen
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·N J Leidenheimer, M D Schechter
Apr 1, 1993·Pharmacology, Biochemistry, and Behavior·E Ergene, E P Schoener
Jan 1, 1983·Neurochemistry International·M Hamon, P Soubrié
Feb 1, 1990·Journal of Ethnopharmacology·J Quetin-LeclercqN G Bisset
Sep 1, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Durk FekkesSusanne L T Cappendijk
Mar 10, 2000·European Journal of Pharmacology·C C ShiC F Chen
Jan 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Renske SpijkermanDurk Fekkes
Jun 1, 1991·Alcoholism, Clinical and Experimental Research·H RommelspacherT May
Aug 1, 1995·Alcoholism, Clinical and Experimental Research·C D SpiesL Hannemann
Jul 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D J TweedieM D Burke
Oct 1, 1988·Alcoholism, Clinical and Experimental Research·T R Bosin, K F Faull
Oct 4, 2011·Journal of Psychopharmacology·Mohammad NasehiMohammad Reza Zarrindast
Jan 6, 1983·Nature·L P Prado de CarvalhoJ Rossier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.